• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级医院中全身炎症反应指数(SIRI)、中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)对急性冠脉综合征预后的预测作用

The predictive role of Systemic Inflammation Response Index (SIRI), Neutrophil-Lymphocyte Ratio (NLR), and Platelet-Lymphocyte Ratio (PLR) in the prognosis of acute coronary syndrome in a tertiary care hospital.

作者信息

Rajakumar Hamrish Kumar, Coimbatore Sathyabal Varsha, Vasanthan Mannar, Dasarathan Ramesh

机构信息

Government Medical College, Omandurar Government Estate, Chennai, 02, Tamilnadu, India.

Department of General Medicine, Government Medical College, Omandurar Government Estate, Chennai, 02, Tamilnadu, India.

出版信息

Heliyon. 2024 Oct 9;10(20):e39029. doi: 10.1016/j.heliyon.2024.e39029. eCollection 2024 Oct 30.

DOI:10.1016/j.heliyon.2024.e39029
PMID:39640781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620114/
Abstract

BACKGROUND

& Objective: Acute coronary syndrome (ACS) is a major cause of mortality globally, with significant morbidity and economic impact. This study aimed to correlate the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic inflammatory response index (SIRI) values in ACS patients with their prognosis via the GRACE scoring criteria and to propose the SIRI as a superior inflammatory marker for predicting ACS prognosis.

METHODS

Ethical approval was obtained for a retrospective cross-sectional study, which included patients from the outpatient department and Tamilnadu Accident Emergency Initiative Ward at Government Medical College, Omandurar Government Estate, who were diagnosed with ACS according to American College of Cardiology guidelines from January 2022 to December 2023. We excluded patients with familial hypercholesterolemia, platelet disorders, infections, inflammatory conditions, or incomplete health records. Data on demographics, clinical findings, blood counts, ECGs, cardiac enzymes, echocardiography, serum creatinine, and vital signs were collected and analyzed to calculate the NLR, PLR, SIRI, and GRACE scores. Statistical analyses included Kolmogorov‒Smirnov and Anderson‒Darling tests, Spearman correlation, Kruskal‒Wallis one-way ANOVA, GLM modeling, k-fold cross-validation, and receiver operating characteristic (ROC) curve analysis.

RESULTS

After applying the exclusion criteria, 247 ACS patients were included in the analysis. Significant associations were found between the NLR and the PLR, SIRI, and GRACE scores. The SIRI demonstrated the strongest association, whereas the PLR had the weakest association. All three variables significantly influenced prognostic risk, as determined by the GRACE score. GLM models highlighted the predictive significance of the NLR, PLR, and SIRI in estimating GRACE scores, with the SIRI showing potential superiority. K-fold cross-validation confirmed the superior predictive accuracy and ability of the SIRI to explain a larger proportion of variance in GRACE scores than the NLR and PLR.

CONCLUSIONS

The SIRI emerges as a promising prognostic marker for ACS, outperforming the NLR and PLR. Its ease of calculation from routine hemogram tests underscores its potential clinical utility for risk stratification in ACS management. Further validation and integration into existing risk assessment models could enhance prognosis assessment in ACS patients.

摘要

背景与目的

急性冠状动脉综合征(ACS)是全球范围内主要的死亡原因,具有显著的发病率和经济影响。本研究旨在通过GRACE评分标准,将ACS患者的中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及全身炎症反应指数(SIRI)值与其预后进行关联,并提出SIRI作为预测ACS预后的更优炎症标志物。

方法

本回顾性横断面研究获得伦理批准,纳入了2022年1月至2023年12月期间在奥曼杜拉尔政府医院政府医学院门诊部和泰米尔纳德邦事故急救倡议病房,根据美国心脏病学会指南被诊断为ACS的患者。我们排除了患有家族性高胆固醇血症、血小板疾病、感染、炎症性疾病或健康记录不完整的患者。收集并分析了人口统计学、临床检查结果、血常规、心电图、心肌酶、超声心动图、血清肌酐和生命体征等数据,以计算NLR、PLR、SIRI和GRACE评分。统计分析包括柯尔莫哥洛夫 - 斯米尔诺夫检验和安德森 - 达林检验、斯皮尔曼相关性分析、克鲁斯卡尔 - 沃利斯单因素方差分析、广义线性模型(GLM)建模、k折交叉验证以及受试者工作特征(ROC)曲线分析。

结果

应用排除标准后,247例ACS患者纳入分析。发现NLR与PLR、SIRI和GRACE评分之间存在显著关联。SIRI显示出最强的关联,而PLR的关联最弱。GRACE评分显示,所有这三个变量均显著影响预后风险。GLM模型突出了NLR、PLR和SIRI在估计GRACE评分方面的预测意义,其中SIRI显示出潜在的优越性。k折交叉验证证实,与NLR和PLR相比,SIRI具有更高的预测准确性和解释GRACE评分中更大比例方差的能力。

结论

SIRI成为ACS有前景的预后标志物,优于NLR和PLR。它易于从常规血常规检查中计算得出,这突出了其在ACS管理风险分层中的潜在临床实用性。进一步验证并整合到现有风险评估模型中可增强ACS患者的预后评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11620114/95e5c9f4c5a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11620114/b9dd7e409d26/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11620114/95e5c9f4c5a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11620114/b9dd7e409d26/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11620114/95e5c9f4c5a7/gr1.jpg

相似文献

1
The predictive role of Systemic Inflammation Response Index (SIRI), Neutrophil-Lymphocyte Ratio (NLR), and Platelet-Lymphocyte Ratio (PLR) in the prognosis of acute coronary syndrome in a tertiary care hospital.三级医院中全身炎症反应指数(SIRI)、中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)对急性冠脉综合征预后的预测作用
Heliyon. 2024 Oct 9;10(20):e39029. doi: 10.1016/j.heliyon.2024.e39029. eCollection 2024 Oct 30.
2
The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值及全身炎症反应指数与短期功能预后的相关性
J Inflamm Res. 2023 Aug 23;16:3619-3630. doi: 10.2147/JIR.S418106. eCollection 2023.
3
The predictive role of composite inflammatory ratio parameters in the conscious awareness recovery after severe acute ischemic stroke: a retrospective cohort study.复合炎症比率参数在严重急性缺血性卒中后意识恢复中的预测作用:一项回顾性队列研究
BMC Neurol. 2025 Mar 6;25(1):90. doi: 10.1186/s12883-024-04016-0.
4
Predictive value of novel inflammatory markers combined with GRACE score for in-hospital outcome in patients with ST-segment elevation myocardial infarction: a retrospective observational study.新型炎症标志物联合GRACE评分对ST段抬高型心肌梗死患者院内结局的预测价值:一项回顾性观察研究
BMJ Open. 2025 Apr 3;15(4):e096621. doi: 10.1136/bmjopen-2024-096621.
5
The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients.全身性炎症反应指数(SIRI)对脑卒中患者预后的预测作用。
Clin Interv Aging. 2021 Dec 1;16:1997-2007. doi: 10.2147/CIA.S339221. eCollection 2021.
6
Evaluating Cardiovascular Risks: The Platelet Lymphocyte Ratio and the Neutrophil Lymphocyte Ratio As High-Risk Heart Score Predictors in Non-ST Elevation Myocardial Infarction (NSTEMI) and Unstable Angina Patients.评估心血管风险:血小板淋巴细胞比率和中性粒细胞淋巴细胞比率作为非ST段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛患者高风险心脏评分预测指标
Cureus. 2024 May 28;16(5):e61279. doi: 10.7759/cureus.61279. eCollection 2024 May.
7
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients.多种基于淋巴细胞的炎症指标对急性冠状动脉综合征患者的预后影响
Front Cardiovasc Med. 2022 May 3;9:811790. doi: 10.3389/fcvm.2022.811790. eCollection 2022.
8
The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage.中性粒细胞与淋巴细胞比值(NLR)、全身免疫炎症指数(SII)、血小板与淋巴细胞比值(PLR)和全身炎症反应指数(SIRI)预测脑出血患者肺炎发生和严重程度的临床价值。
Front Immunol. 2023 Feb 13;14:1115031. doi: 10.3389/fimmu.2023.1115031. eCollection 2023.
9
The Association of Neutrophil to Lymphocyte Ratio and Other Complete Blood Count Parameters with Global Registry of Acute Coronary Events Risk Score in Patients with Non-ST Segment Elevation - Acute Coronary Syndrome: A Single-Center Study.非ST段抬高型急性冠状动脉综合征患者中性粒细胞与淋巴细胞比值及其他全血细胞计数参数与急性冠状动脉事件全球注册风险评分的相关性:一项单中心研究
Med J Islam Repub Iran. 2024 Sep 23;38:109. doi: 10.47176/mjiri.38.109. eCollection 2024.
10
Predictive Role of Blood Cell-Derived Inflammatory Markers for the Risk of Asymptomatic Cerebral Infarction in Essential Hypertension: A Population-Based Cross-Sectional Study in Central China.血细胞源性炎症标志物对原发性高血压患者无症状性脑梗死风险的预测作用:一项基于中国中部地区人群的横断面研究
J Inflamm Res. 2025 Mar 11;18:3523-3534. doi: 10.2147/JIR.S505385. eCollection 2025.

引用本文的文献

1
Prognostic Role of Inflammatory Hematologic Indices in Predicting Acute Coronary Syndrome in Elderly Patients with Chronic Coronary Syndrome.炎症血液学指标在预测老年慢性冠状动脉综合征患者急性冠状动脉综合征中的预后作用
J Inflamm Res. 2025 Jul 22;18:9637-9653. doi: 10.2147/JIR.S528161. eCollection 2025.
2
Hair Calcium Levels in Relation to Coronary Artery Disease Severity and Systemic Inflammation Markers: A Pilot Study.头发钙水平与冠状动脉疾病严重程度及全身炎症标志物的关系:一项初步研究。
J Clin Med. 2025 Jun 26;14(13):4537. doi: 10.3390/jcm14134537.
3
Inflammatory Indices in Patients with Myocardial Infarction Complicated by Cardiogenic Shock, and Their Interconnections with SCAI Stages and Patients' Survival: A Retrospective Study.

本文引用的文献

1
Predictive Value of the Modified GRACE Scoring System for All-Cause Mortality in Patients with Acute Myocardial Infarction.改良GRACE评分系统对急性心肌梗死患者全因死亡率的预测价值
Rev Cardiovasc Med. 2023 Jun 6;24(6):161. doi: 10.31083/j.rcm2406161. eCollection 2023 Jun.
2
Hematological biomarkers of troponin, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio serve as effective predictive indicators of high-risk mortality in acute coronary syndrome.肌钙蛋白、中性粒细胞与淋巴细胞比值以及单核细胞与淋巴细胞比值等血液生物标志物是急性冠状动脉综合征高危死亡率的有效预测指标。
Biomedicine (Taipei). 2023 Dec 1;13(4):32-43. doi: 10.37796/2211-8039.1425. eCollection 2023.
3
心肌梗死合并心源性休克患者的炎症指标及其与SCAI分期和患者生存的相关性:一项回顾性研究
J Clin Med. 2025 Jun 16;14(12):4283. doi: 10.3390/jcm14124283.
To Evaluate Platelet Indices, Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Prognostic and Risk Factors in Patients with Coronary Artery Disease.
评估血小板指标、血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值作为冠状动脉疾病患者的预后和危险因素。
Indian J Hematol Blood Transfus. 2024 Jan;40(1):103-107. doi: 10.1007/s12288-023-01664-z. Epub 2023 Jun 21.
4
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
5
Global epidemiology of acute coronary syndromes.急性冠状动脉综合征的全球流行病学
Nat Rev Cardiol. 2023 Nov;20(11):778-788. doi: 10.1038/s41569-023-00884-0. Epub 2023 May 25.
6
Is Systemic Inflammatory Response Index (SIRI) a Reliable Tool for Prognosis of Gastric Cancer Patients Without Neoadjuvant Therapy?全身炎症反应指数(SIRI)是否是未经新辅助治疗的胃癌患者预后的可靠工具?
Cureus. 2023 Mar 23;15(3):e36597. doi: 10.7759/cureus.36597. eCollection 2023 Mar.
7
The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.全身炎症反应指数(SIRI)和肿瘤浸润淋巴细胞(TILs)在喉鳞状细胞癌患者预后中的作用。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5627-5636. doi: 10.1007/s00432-022-04469-1. Epub 2022 Dec 15.
8
Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.全身炎症反应指数对行经皮冠状动脉介入治疗的急性冠状动脉综合征患者的预后价值。
Ann Med. 2022 Dec;54(1):1667-1677. doi: 10.1080/07853890.2022.2083671.
9
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients.多种基于淋巴细胞的炎症指标对急性冠状动脉综合征患者的预后影响
Front Cardiovasc Med. 2022 May 3;9:811790. doi: 10.3389/fcvm.2022.811790. eCollection 2022.
10
Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study.系统性炎症反应指数(SIRI)作为类风湿关节炎患者的新型生物标志物:一项多中心回顾性研究。
Clin Rheumatol. 2022 Jul;41(7):1989-2000. doi: 10.1007/s10067-022-06122-1. Epub 2022 Mar 9.